Sosei Group Revenue and Competitors
Estimated Revenue & Valuation
- Sosei Group's estimated annual revenue is currently $35.3M per year.
- Sosei Group's estimated revenue per employee is $155,000
Employee Data
- Sosei Group has 228 Employees.
- Sosei Group grew their employee count by 9% last year.
Sosei Group's People
Name | Title | Email/Phone |
---|---|---|
1 | Head Clinical Operations | Reveal Email/Phone |
2 | Senior Scientist II | Reveal Email/Phone |
3 | Researcher | Reveal Email/Phone |
Sosei Group Competitors & AlternativesAdd Company
Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
---|---|---|---|---|---|
#1 | $81.4M | 375 | 40% | N/A | N/A |
#2 | $16.9M | 109 | 22% | N/A | N/A |
#3 | $156.1M | 120 | -70% | $145M | N/A |
#4 | $2.9M | 37 | -24% | $150M | N/A |
#5 | $1.3M | 17 | 0% | $459.5M | N/A |
#6 | $49.2M | 254 | 15% | $180.7M | N/A |
#7 | $7M | 45 | -2% | N/A | N/A |
#8 | $256.3M | 840 | 9% | $168.5M | N/A |
#9 | $4.2M | 27 | -7% | N/A | N/A |
#10 | $10.1M | 65 | 5% | N/A | N/A |
What Is Sosei Group?
We are an international biopharmaceutical group focused on the discovery and early development of new medicines originating from our proprietary GPCR-targeted StaR® technology and structure-based drug design platform capabilities. We are advancing a broad and deep pipeline of novel medicines across multiple therapeutic areas, including neurology, immunology, gastroenterology and inflammatory diseases. We have established partnerships with some of the world's leading pharmaceutical companies, including AbbVie, AstraZeneca, Genentech (Roche), Novartis, Pfizer and Takeda and additionally with multiple emerging technology companies. Sosei Heptares is headquartered in Tokyo, Japan with corporate and R&D facilities in Cambridge, UK. Sosei Heptares is the corporate brand of Sosei Group Corpoation, which is listed on the Tokyo Stock Exchange (ticker: 4565). For more information, please visit www.soseiheptares.com
keywords:N/AN/A
Total Funding
228
Number of Employees
$35.3M
Revenue (est)
9%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Sosei Group News
TOKYO and CAMBRIDGE, United Kingdom, April 26, 2022 (GLOBE NEWSWIRE) -- Sosei Group Corporation (the Company; TSE: 4565) today announces a...
Tokyo, Japan and Cambridge, UK, 26 April 2022 Sosei Group Corporation (the Company; TSE: 4565) today announces a strategic collaboration...
Hironoshin Nomura becomes CFO and Kieran Johnson becomes chief accounting officer in other changes at the company, which said the new team would...
Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
---|---|---|---|---|
#1 | $35.3M | 228 | 9% | N/A |
#2 | $88.2M | 243 | 11% | N/A |
#3 | $40.5M | 254 | 9% | N/A |
#4 | $37.3M | 261 | 110% | $260.4M |
#5 | $39.2M | 274 | 40% | N/A |